首頁 › 膀胱癌 › 堪薩斯 › Kansas City
Kansas City, KS 的 膀胱癌 臨床試驗
12 項針對 膀胱癌 的研究正在 Kansas City(約 30 英里範圍內)及其周邊地點尋找參與者。開啟研究以查看參與資格及聯絡研究團隊的方式。
官方研究文本(英文)
正在為研究招募對象嗎?將此頁面置頂展示 — $99 / 30 天 →
Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to Radiation Therapy Compared to the Usual Chemotherapy Treatment During Radiation Therapy for Bladder Cancer, PARRC Trial
招募中2 期
- University of Kansas Cancer Center, Kansas City
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
招募中觀察性研究歡迎健康志工
- Veteran Administration Eastern Kansas Healthcare, Leavenworth · 距離 21 英里
A Study to Learn About the Study Medicine PF-08052667 in People With Bladder Cancer
招募中1 期
- The University of Kansas Hospital Cambridge North Tower A, Kansas City
- The University of Kansas Hospital, Kansas City
- The University of Kansas Medical Center Medical Office Building, Kansas City
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients Receiving the Usual Chemotherapy Treatment for Bladder Cancer, ARCHER Study
招募中3 期
- University of Kansas Cancer Center, Kansas City
A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors
招募中1/2 期
- The University of Kansas Cancer Center, Kansas City
LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve
招募中1/2 期
- University of Kansas Medical Center, Kansas City
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
招募中1 期
- The University of Kansas Hospital, Kansas City
- The University of Kansas Medical Center Medical Office Building, Kansas City
- University of Kansas Hospital Cambridge North Tower A, Kansas City
- 還有 1 項
Metabolism Evaluation Through Resting Indirect Calorimetry in Bladder Cancer (METRICS)
招募中觀察性研究
- University of Kansas Medical Center, Kansas City
- University of Kansas Medical Center, Kansas City
Bladder Cancer Longitudinal Biorepository for Development of Novel Therapeutics/Biomarkers
招募中觀察性研究
- University of Kansas Medical Center, Kansas City
Blue Light Cystoscopy With Cysview® Registry
招募中觀察性研究
- University of Kansas Medical Center, Kansas City
Intravenous Ascorbate Plus Gemcitabine/Carboplatin: A Novel and Cost-Effective Alternative With Evident Efficacy in Patients With Muscle Invasive Bladder Cancer
招募中2 期
- The University of Kansas Cancer Center, Kansas City
LaserEn: SOLTIVE™ Thulium Laser Fiber En Bloc Resection of Bladder Tumors
招募中觀察性研究
- University of Kansas Medical Center, Kansas City
其他城市的 膀胱癌 試驗
- New York City, NY35 項研究
- Houston, TX31 項研究
- Nashville, TN31 項研究
- Dallas, TX27 項研究
- Washington, DC26 項研究
- Boston, MA26 項研究
- Baltimore, MD24 項研究
- Los Angeles, CA24 項研究
- St. Louis, MO22 項研究
- Seattle, WA21 項研究
- Chicago, IL21 項研究
- Philadelphia, PA21 項研究
Kansas City 的其他研究
- 心血管疾病14 項研究
- 心臟衰竭13 項研究
- 肥胖症13 項研究
- 間質性肺病13 項研究
- 囊腫性纖維化13 項研究
- 乳癌12 項研究
- 急性髓系白血病12 項研究
- 前列腺癌12 項研究
- 非小細胞肺癌11 項研究
- 肺癌11 項研究
- 慢性阻塞性肺病9 項研究
- 氣喘8 項研究
資料來源:ClinicalTrials.gov,擷取日期 2026年10月6日。各研究自行設定資格標準;由研究團隊決定參與者資格。